Analysis
Lexicon Pharmaceuticals (LXRX) Q4 Loss Narrows to $0.04 Per Share Despite 79% Revenue Plunge to $5.5M
Lexicon narrows Q4 loss to $0.04 per share from $0.09 year-ago, but revenue plunges 79% to $5.5M amid commercialization challenges.